Literature DB >> 6477954

Characterization of high-density lipoprotein binding sites in rat liver and testis membranes.

G K Chacko.   

Abstract

The binding of human 125I-labeled HDL3 to purified rat liver and testis plasma membranes was studied. About 50-65% of the total HDL binding in these membranes was abolished by 1% bovine serum albumin in the incubation medium. The remaining albumin-insensitive binding sites, determined in the presence of albumin were associated with plasma membranes; a good correlation was found between the 125I-labeled HDL3 binding and the 5'-nucleotidase activities of the membrane fractions. The binding sites in these tissues were saturable, specific for HDL (not competed for by LDL) and had similar affinities for 125I-labeled HDL3 (Kd, 11.8 micrograms protein/ml for liver and 12.7 micrograms protein/ml for testis membranes); the maximum binding capacity of the testis membranes was higher (1.3 vs. 0.7 microgram protein/mg membrane protein). Egg phosphatidylcholine complexes of both human apolipoprotein A-I and apolipoprotein C's competed for the HDL-binding sites, but phosphatidylcholine vesicles alone did not. Chemical modification of the lysine and arginine residues of apolipoproteins did not affect the interaction of HDL3 with its binding sites. Despite the fact that the HDL-binding sites in these tissues are not specific for apolipoprotein A-I, they may have important physiological roles in lipid transport, as they appear to recognize apolipoprotein-phospholipid complexes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477954     DOI: 10.1016/0005-2760(84)90093-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Purification and characterization of two high-density-lipoprotein-binding proteins from rat and human liver.

Authors:  M Tozuka; N Fidge
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

2.  Imbalanced testicular metabolism induced by thyroid disorders: New evidences from quantitative proteome.

Authors:  Samantha Nascimento Gomes; Deborah Elzita do Carmo Corrêa; Isabela Medeiros de Oliveira; Paula Bargi-Souza; Monica Degraf Cavallin; Danielle Dobner Mariano; Najeh Maissar Khalil; David Livingstone Alves Figueiredo; Marco Aurelio Romano; Claudio Alvarenga de Oliveira; Renata Marino Romano
Journal:  Endocrine       Date:  2019-06-29       Impact factor: 3.633

3.  Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia.

Authors:  A Corsini; P Roma; D Sommariva; R Fumagalli; A L Catapano
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

4.  Acute presentation of Tangier polyneuropathy: a clinical and morphological study.

Authors:  R Fazio; R Nemni; A Quattrini; G Ruotolo; S Iannaccone; D Mamoli; M Lodi; N Canal
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Interaction in vivo and in vitro of apolipoprotein E-free high-density lipoprotein with parenchymal, endothelial and Kupffer cells from rat liver.

Authors:  D Schouten; M Kleinherenbrink-Stins; A Brouwer; D L Knook; T J Van Berkel
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

6.  Affinity purification of the hepatic high-density lipoprotein receptor identifies two acidic glycoproteins and enables further characterization of their binding properties.

Authors:  H Hidaka; N H Fidge
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

7.  A recombinant apoA-1--protein A hybrid reproduces the binding parameters of HDL to its receptor.

Authors:  L Monaco; H M Bond; K E Howell; R Cortese
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.